RCM
IBB icon

RB Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

RB Capital Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$470K Hold
2,473
– – 0.09% 137
2026
Q1 		$418K Hold
2,473
– – 0.09% 134
2025
Q4 		$417K Buy
2,473
+1
+0% +$162 0.08% 137
2025
Q3 		$357K Buy
2,472
+1
+0% +$136 0.07% 140
2025
Q2 		$313K Hold
2,471
– – 0.07% 149
2025
Q1 		$316K Hold
2,471
– – 0.07% 141
2024
Q4 		$327K Buy
2,471
+1
+0% +$141 0.07% 142
2024
Q3 		$360K Buy
2,470
+1
+0% +$145 0.08% 136
2024
Q2 		$339K Hold
2,469
– – 0.08% 138
2024
Q1 		$339K Buy
2,469
+1
+0% +$137 0.09% 142
2023
Q4 		$335K Buy
2,468
+1
+0% +$122 0.1% 134
2023
Q3 		$302K Hold
2,467
– – 0.09% 137
2023
Q2 		$313K Hold
2,467
– – 0.09% 137
2023
Q1 		$319K Sell
2,467
-51
-2% -$6.68K 0.1% 139
2022
Q4 		$331K Buy
2,518
+54
+2% +$6.98K 0.12% 132
2022
Q3 		$288K Sell
2,464
-20
-0.8% -$2.48K 0.11% 133
2022
Q2 		$292K Hold
2,484
– – 0.11% 139
2022
Q1 		$324K Buy
2,484
+1
+0% +$130 0.1% 135
2021
Q4 		$379K Hold
2,483
– – 0.12% 127
2021
Q3 		$401K Hold
2,483
– – 0.15% 117
2021
Q2 		$406K Buy
2,483
+1
+0% +$154 0.15% 116
2021
Q1 		$374K Hold
2,482
– – 0.17% 109
2020
Q4 		$376K Sell
2,482
-279
-10% -$39.9K 0.17% 102
2020
Q3 		$385K Buy
2,761
+100
+4% +$13.6K 0.18% 98
2020
Q2 		$364K Buy
2,661
+1
+0% +$127 0.19% 98
2020
Q1 		$287K Sell
2,660
-7,542
-74% -$868K 0.18% 97
2019
Q4 		$220K Buy
+10,202
New +$1.14M 0.13% 122

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

RB Capital Management's IBB Position: Q2 2026 in Review

RB Capital Management held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 2,473 shares worth $470K. The position accounts for 0.09% of the portfolio, ranked #137.

RB Capital Management first reported a position in IBB in Q4 2019 and has held it in 27 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • RB Capital Management held 2,473 shares of iShares Biotechnology ETF worth $470K as of Q2 2026.
  • RB Capital Management left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up 0.09% of RB Capital Management's portfolio in Q2 2026, its #137 holding.
  • RB Capital Management first reported a position in iShares Biotechnology ETF in Q4 2019 and has held it in 27 quarters since.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on RB Capital Management's 13F filing for Q2 2026, filed 18 Aug 2026.